JNJ-40346527
- Generic Name
- JNJ-40346527
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C27H35N5O2
- CAS Number
- 1142363-52-7
- Unique Ingredient Identifier
- 3NU609VYNF
- Background
JNJ-40346527 has been used in trials studying the treatment of Health and Arthritis, Rheumatoid.
- Associated Conditions
- -
- Associated Therapies
- -
MIcroglial Colony Stimulating Factor-1 Receptor (CSF1R) in Alzheimer's Disease
Phase 1
Terminated
- Conditions
- Interventions
- First Posted Date
- 2019-10-09
- Last Posted Date
- 2024-05-09
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 2
- Registration Number
- NCT04121208
- Locations
- 🇬🇧
South London and Maudsley Hospital NHS Foundation Trust, London, United Kingdom
🇬🇧Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, United Kingdom
🇬🇧Oxford Health NHS Trust, Oxford, United Kingdom
A Study of JNJ-40346527 in Patients With Active Rheumatoid Arthritis Despite Disease-modifying Antirheumatic Drug Therapy
- First Posted Date
- 2012-05-14
- Last Posted Date
- 2014-04-08
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 96
- Registration Number
- NCT01597739
A Single and Multiple Dose Study to Explore the Safety Of JNJ-40346527 In Healthy Volunteers
- First Posted Date
- 2010-01-22
- Last Posted Date
- 2013-09-04
- Target Recruit Count
- 120
- Registration Number
- NCT01054014
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath